Table 1.
Relationship between expression of miR‑100 and clinical characteristics of MCL cases
Clinical features | n | High miR-100 | Low miR-100 | χ2 | p value |
---|---|---|---|---|---|
Age (years) | 0.9 | 0.3428 | |||
≤ 58 | 8 | 5 | 3 | ||
>58 | 10 | 4 | 6 | ||
Sex | 0.2769 | 0.5987 | |||
Male | 13 | 6 | 7 | ||
Female | 5 | 3 | 2 | ||
B symptoms | 2.25 | 0.1336 | |||
Present | 2 | 0 | 2 | ||
Absent | 16 | 9 | 7 | ||
LDH (U/L) | 6.923 | 0.0085 | |||
<300 | 13 | 9 | 4 | ||
≥ 300 | 5 | 0 | 5 | ||
Clinical stage | 3.6 | 0.0578 | |||
I–II | 3 | 3 | 0 | ||
III–IV | 15 | 6 | 9 | ||
IPI score | 5.844 | 0.0156 | |||
<3 | 11 | 8 | 3 | ||
≥ 3 | 7 | 1 | 6 | ||
Involve bone marrow | 0.2338 | 0.6287 | |||
Present | 11 | 5 | 6 | ||
Absent | 7 | 4 | 3 |